Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Study Confirms NEM’s Efficacy and Support of Inflammatory Response - Nutraceuticals World

What are you searching for?

Sign in
Research

Study Confirms NEM’s Efficacy and Support of Inflammatory Response

By: Lisa Olivo

, Rodman Media

Stratum Nutrition and ESM Technologies presented newly published research demonstrating NEM eggshell membrane’s method of action, and support of healthy inflamatory response.
 
In collaboration with the Jordan Valley Innovation Center within Missouri State University, the scientists evaluated three different hydrolyzates of eggshell membrane (fermentation, enzymatic, or chemical) in cell cultures of two different types of human immune cells. All three hydrolyzates were found to activate the gene transcription factor NF-kB, although the chemical hydrolyzate was about 10-fold less effective versus the fermentation and enzymatic hydrolyzates. NF-kB plays a fundamental role in the functioning of the immune system and occurs very early in the inflammatory cascade. Dysregulation of NF-kB has been implicated in the development of a number of classical inflammatory diseases such as rheumatoid arthritis, asthma, and inflammatory bowel disease. Interestingly, NF-kB dysregulation has also been associated with diseases such as diabetes, Alzheimer’s Disease, and multiple sclerosis which are not traditionally thought of as inflammatory in nature.
 
“It’s always rewarding to gain insight into the observed efficacy of one of our ingredients through fundamental research, particularly when this leads to the potential for new intellectual property,” commented Dr. Kevin J. Ruff, Director of Scientific & Regulatory Affairs for ESM Technologies, the manufacturer of NEM.  The results of these studies were published in the February issue of the Journal of Inflammation Research (DOI: http://dx.doi.org/10.2147/JIR.S78118).
 
For more information: www.esmingredients.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics